BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23563652)

  • 1. Sphingolipids and response to chemotherapy.
    Dimanche-Boitrel MT; Rebillard A
    Handb Exp Pharmacol; 2013; (216):73-91. PubMed ID: 23563652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
    Modrak DE
    Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Kartal Yandım M; Apohan E; Baran Y
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):13-20. PubMed ID: 23073611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
    Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
    Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of sphingosine kinase and sphingolipid signaling.
    Pitson SM
    Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.
    Gencer EB; Ural AU; Avcu F; Baran Y
    Ann Hematol; 2011 Nov; 90(11):1265-75. PubMed ID: 21455605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
    Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
    Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the ceramide system in cancer.
    Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
    Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sphingolipids in respiratory disease.
    Yang Y; Uhlig S
    Ther Adv Respir Dis; 2011 Oct; 5(5):325-44. PubMed ID: 21900155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase-1--a potential therapeutic target in cancer.
    Cuvillier O
    Anticancer Drugs; 2007 Feb; 18(2):105-10. PubMed ID: 17159597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
    Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the sphingolipid rheostat is involved in paclitaxel resistance of the human prostate cancer cell line PC3-PR.
    Aoyama Y; Sobue S; Mizutani N; Inoue C; Kawamoto Y; Nishizawa Y; Ichihara M; Kyogashima M; Suzuki M; Nozawa Y; Murate T
    Biochem Biophys Res Commun; 2017 Apr; 486(2):551-557. PubMed ID: 28322796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases.
    Canals D; Perry DM; Jenkins RW; Hannun YA
    Br J Pharmacol; 2011 Jun; 163(4):694-712. PubMed ID: 21615386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of bioactive sphingolipids in cancer biology and therapeutics.
    Saddoughi SA; Song P; Ogretmen B
    Subcell Biochem; 2008; 49():413-40. PubMed ID: 18751921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on the role of sphingosine 1-phosphate in cancer.
    Pyne S; Pyne NJ
    Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles, regulation and inhibitors of sphingosine kinase 2.
    Neubauer HA; Pitson SM
    FEBS J; 2013 Nov; 280(21):5317-36. PubMed ID: 23638983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.